Dr. Joon Uhm, MD
Claim this profileMayo Clinic
Studies Benign Glioma
Studies Glioblastoma
2 reported clinical trials
5 drugs studied
Area of expertise
1Benign Glioma
Stage III
Stage IV
2Glioblastoma
Stage III
Stage IV
Affiliated Hospitals
Mayo Clinic
Clinical Trials Joon Uhm, MD is currently running
More about Joon Uhm, MD
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Joon Uhm, MD has experience with
- APG-157
- Bevacizumab
- Epacadostat
- Radiation Therapy
- Retifanlimab
Breakdown of trials Joon Uhm, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joon Uhm, MD specialize in?
Joon Uhm, MD focuses on Benign Glioma and Glioblastoma. In particular, much of their work with Benign Glioma has involved Stage III patients, or patients who are Stage IV.
Is Joon Uhm, MD currently recruiting for clinical trials?
Yes, Joon Uhm, MD is currently recruiting for 1 clinical trial in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Joon Uhm, MD has studied deeply?
Yes, Joon Uhm, MD has studied treatments such as APG-157, Bevacizumab, Epacadostat.
What is the best way to schedule an appointment with Joon Uhm, MD?
Apply for one of the trials that Joon Uhm, MD is conducting.
What is the office address of Joon Uhm, MD?
The office of Joon Uhm, MD is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.